The influence of randomized trials on the use of anticoagulants for atrial fibrillation | Zendy

G E Mead | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The influence of randomized trials on the use of anticoagulants for atrial fibrillation

Author(s) -

G E Mead

Publication year - 1999

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/28.5.441

Subject(s) - medicine , atrial fibrillation , stroke (engine) , cardiology , sinus rhythm , randomized controlled trial , retinal artery occlusion , anticoagulant , odds ratio , occlusion , confidence interval , anesthesia , retinal , ophthalmology , mechanical engineering , engineering

Anticoagulants and anti-platelet drugs have been shown in randomized trials to reduce the risk of stroke in patients with atrial fibrillation (AF). We therefore investigated their use in patients known to be in AF before a stroke, transient ischaemic attack (either cerebral or ocular) or retinal artery occlusion to assess the influence of trials on clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research